Zusammenfassung
Reflexionen zum Verhältnis von Mensch und Technik durchziehen die Technikphilosophie und angrenzende Bereiche spätestens seit den grundlegenden Überlegungen von Karl Marx (vgl. Quante 2013) und haben vor allem im deutschsprachigen Raum wesentliche Anregungen durch Arnold Gehlen (vgl. Gutmann 2013) und andere Vertreter der Philosophischen Anthropologie erhalten. Visionen einer Technisierung des Menschen, einer „Verwissenschaftlichung“ gesellschaftlicher Beziehungen und eines Verschmelzens von Mensch und Technik – die aktuell insbesondere aufgrund des sog. ‚Transhumanismus‘ und im Diskurs über ‚Cyborgs‘ viel diskutiert werden – gewinnen im Verlauf des 20.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Babcock Q, Byrne T (2000) Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 49: 143-145
Bechmann G. (1993) Ethische Grenzen der Technik oder technische Grenzen der Ethik? Geschichte und Gegenwart. Vierteljahreshefte für Zeitgeschichte, Gesellschaftsanalyse und politische Bildung 12: 213-225
Beck S (Hg) (2012) Gehört mein Körper noch mir? Strafgesetzgebung zur Verfügungsbefugnis über den eigenen Körper in den Lebenswissenschaften. Baden-Baden
Béland JP, et al. (2011) The Social and Ethical Acceptability of NBICs for Purposes of Human Enhancement: Why Does the Debate Remain Mired in Impasse? NanoEthics 5(3): 295-307
Boenink M, Swierstra T, Stemerding D (2010) Anticipating the interaction between technology and morality: a scenario study of experimenting with humans in bionanotechnology. Stud Ethics Law Tech 4(2)
Bogle KE, Smith BH (2009) Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr Drug Abuse Rev May 2(2): 157-176
Bogner A (Hg) (2013) Ethisierung der Technik – Technisierung der Ethik. Der Ethik-Boom im Lichte der Wissenschafts- und Technikforschung. Baden-Baden
Brey PAE (2012) Anticipatory Ethics for Emerging Technologies. NanoEthics 6(1): 1-13
Caldera EO (2008) Cognitive Enhancement and Theories of Justice: Contemplating the Malleability of Nature and Self. In: The Journal of Evolution and Technology 18 (01), http://jetpress.org/v18/caldera.htm
Caldwell J, et al. (2004) The efficacy of modafinil for sustaining alertness and simulator flight performance in F-117 pilots during 37 hours of continuous wakefulness. U. S. Air Force Research Laboratory Technical Report AFRLHE-BR-TR-2004-0003
Chatterjee A (2006) The promise and predicament of cosmetic neurology. Journal of Medical Ethics 32: 110-113
Chatterjee A (2013) The ethics of neuroenhancement. Handbook of Clinical Neurology 118: 323–334
Christmas D, et al. (2014) A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers. Hum Psychopharmacol Jan 14: https://doi.org/10.1002/hup.2384
Clatworthy PL, et al. (2009) Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. Journal of Neuroscience 29: 4690-4696
Coenen C (2008) Von der Leistungs- zur Leistungssteigerungsgesellschaft? TAB-Brief 33 (Büro für Technikfolgen-Abschätzung, Berlin): 21-27
Coenen C (2010) Deliberating Visions: The Case of Human Enhancement in the Discourse on Nanotechnology and Convergence. In: Kaiser M et al. (2009): 73-88
Coenen C (2013) Converging technologies. In: Gramelsberger G, Bexte P, Kogge W (2013): 209-230
Coenen C, et al. (2009) Human enhancement. Brussels: European Parliament, http://www.itas.fzk.de/deu/lit/2009/coua09a.pdf
Coenen C (2013) Nachdarwinsche Visionen einer technischen Transformation der Menschheit. In: Ebert U, Riha O, Zerling L (2013): 9-36
Coenen C, Simakova E (2013) STS policy interactions, technology assessment and the governance of technovisionary sciences. In: Science, Technology & Innovation Studies 9(2): 3-20
Collingridge D (1980) The social control of technology. London
Cooper AC (1999) The slippery slope and technological determinism. Princeton Journal of Bioethics 2(1): 64-76
de Jongh R, et al. (2008) Botox for the brain: Enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience and Biobehavioral Reviews 32(4): 760-776
Decker M, Ladikas M (Hg) (2004) Bridges between Science, Society and Policy. Technology Assessment – Methods and Impacts. Berlin
DEEPEN (2009) Reconfiguring Responsibility. Deepening Debate on Nanotechnology. www.geography.dur.ac.uk/projects/deepen
DGPPN (2009) Stellungnahme der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) zum Gebrauch von Neuroenhancern, 2009, http://www.dgppn.de/publikationen/stellungnahmen/detailansicht/select/stellungnahmen-2009/article/141/stellungnahm-3.html
Dresler M, et al. (2013) Non-pharmacological cognitive enhancement. Neuropharmacology 64: 529-543
Ebert U, Riha O, Zerling L (Hg) (2013) Der Mensch der Zukunft - Hintergründe, Ziele und Probleme des Human Enhancement (Abhandlungen der Sächsischen Akademie der Wissenschaften; Bd. 82/3). Stuttgart, Leipzig
Elliott R, et al. (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131: 196-206
Elliott C (1998) What’s wrong with enhancement technologies? CHIPS Public Lecture, University of Minnesota, February 26, 1998, Center for Bioethics, University of Minnesota, http://www.ucl.ac.uk/~ucbtdag/bioethics/writings/Elliott.html
Emanuel R, et al. (2013) Cognitive enhancement drug use among future physicians: Findings from a multi-institutional census of medical students. Journal of General Internal Medicine 28(8): 1028-1034
Esposito R, et al. (2013) Acute effects of Modafinil on Brain resting state networks in young healthy subjects. In: PLOS One 8(7): e69224
Farah MJ, et al. (2004) Neurocognitive enhancement: What can we do and what should we do? Nature Reviews Neuroscience 5(5): 421-425
Farah MJ (2011) Overcorrecting the neuroenhancement discussion. Addiction 106(6): 1190, author reply 1190-1191
Ferrari A (2012) Autonomie und Visionen in der Debatte um pharmakologisches Cognitive Enhancement (PCE). In: Beck S (2012): 347-367
Ferrari A, et al. (2012) Visions and ethics in current discourse on human enhancement. NanoEthics 6(3): 215-229
Finger G, et al. (2013) Use of methylphenidate among medical students: a systematic review. Rev assoc med bras. 59(3): 285-289
Forlini C, Racine E (2009a) Autonomy and coercion in academic “cognitive enhancement” using methylphenidate: perspectives of key stakeholders. Neuroethics 2(3): 163-177
Forlini C, Racine E (2009b) Disagreements with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics 10
Forlini C, Racine E (2010) Response. Journal of Bioethical Inquiry 7(4): 383-384
Forlini C, Racine E (2013) Does the cognitive enhancement debate call for a renewal of the deliberative role of bioethics? In: Hildt E, Franke A (2013): 173-186
Fox RC, Swazey JP (2008) Observing Bioethics. Oxford
Franke A, et al. (2011) Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 44: 60-66
Galert T, et al. (2009) Das optimierte Gehirn. Gehirn und Geist 11. http://zeus.zeit.de/wissen/2009-10/memorandum-gehirn-geist.pdf
Gramelsberger G, Bexte P, Kogge W (Hg) (2013) Synthesis. Zur Konjunktur eines philosophischen Begriffs in Wissenschaft und Technik. Bielefeld
Goordjin B (2005) Nanoethics: From Utopian Dreams and Apocalyptic Nightmares Towards a More Balanced View. Science and Engineering Ethics 11(4): 521-533
Greely H, et al. (2008) Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456: 702-705
Grunwald A (2010) From Speculative Nanoethics to Explorative Philosophy of Nanotechnology. NanoEthics 4(2): 91-101
Grunwald A (2006) Nanotechnologie als Chiffre der Zukunft. In: Nordmann A, Schummer J, Schwarz A (2006): 49-80
Grunwald A (2007) Converging Technologies: Visions, Increased Contingencies of the Conditio Humana, and Search for Orientation. Futures 39(4): 380-392
Grunwald A (2008) Auf dem Weg in eine nanotechnologische Zukunft. Freiburg/München
Grunwald A (2009) Technology Assessment: Concepts and Methods. In: Meijers A (Hg) Philosophy of Technology and Engineering Sciences. Volume 9. Amsterdam. S 1103-1146
Grunwald A (2011) Energy futures: Diversity and the need for assessment. Futures 43: 820-830
Grunwald A (2012) Technikzukünfte als Medium von Zukunftsdebatten und Technikgestaltung. Karlsruhe: KIT Scientific Publishing
Grunwald A (2013) Techno-visionary Sciences: Challenges to Policy Advice. Science, Technology and Innovation Studies 9(2): 21-38
Hall SS (2003) The quest for a smart pill. Scientific American 289(3): 54-65
Hall W, Lucke J (2010) The enhancement use of neuropharmaceuticals: More scepticism and caution needed. Addiction 105(12): 2041-2043
Hansson SO (2006) Great Uncertainty about small Things. In: Schummer J, Baird D (2006): 315-325
Harris J (2010) Enhancing Evolution: The Ethical Case for Making Better People. Princeton
Harris J, Chatterjee A (2009) Is it acceptable for people to take methylphenidate to enhance performance? YES and NO. British Medical Journal 338: 1532-1533
Hartley LR, et al. (1983) The effect of beta adrenergic blocking drugs on speakers’ performance and memory. British Journal of Psychiatry 142: 512-517
Hays S, et al. (2011) Public Attitudes Towards Nanotechnology-Enabled Cognitive Enhancement in the United States. In: Hays S, et al. (2011a): 43-65
Hays S, et al. (Hg) (2011a) The Yearbook of Nanotechnology: Nanotechnology, the Brain, and the Future, Volume III. New York
Hedgecoe A (2010) Bioethics and the reinforcement of socio-technical expectations. Social Studies of Science 40(2): 163-186
Heil R, Coenen C (2013) Zukünfte menschlicher Natur: Biovisionäre Diskurse von der Eugenik bis zum Human Enhancement. Technikfolgenabschätzung - Theorie und Praxis 22(1): 23-31
Hildt E (2011) Neuroenhancement Bubble? — Neuroenhancement Wave! In: AJOB Neuroscience 2(4): 44-45
Hildt E, Franke A (Hg) (2013) Cognitive enhancement: An interdisciplinary perspective. New York
Jasanoff S, Kim SH (2009) Containing the Atom: Sociotechnical Imaginaries and Nuclear Power in the United States and South Korea. Minerva 47: 119-146
Kaiser M. et al. (Hg) (2009, 2010) Governing Future Technologies. Nanotechnology and the Rise of an Assessment Regime. Dordrecht
Karafyllis NC (2009) Facts or Fiction? A Critique on Vision Assessment as a Tool for Technology Assessment. In: Sollie P, Düwell M (2009): 93-117
Keiper A (2007) Nanoethics as a Discipline? The New Atlantis. A Journal of Technology & Science 16: 55-67
Kettner M (2009) Wunscherfüllende Medizin - Ärztliche Behandlung im Dienst von Selbstverwirklichung und Lebensplanung. Frankfurt/M
Khushf G (2005) The Use of Emergent Technologies for Enhancing Human Performance: Are We Prepared to Address the Ethical and Political Issues? Public Policy & Practice 4(2): 1-17
Kogge W (2008) Technologie des 21. Jahrhunderts. Perspektiven der Technikphilosophie. Deutsche Zeitschrift für Philosophie 56(6): 935-956
Kraemer F (2011) Authenticity anyone? The enhancement of emotions via neuropsychopharmacology. Neuroethics 4(1): 51- 64
Larriviere D, et al. (2009) Responding to requests from adult patients for neuroenhancements. Guidance of the Ethics, Law and Humanities Committee. Neurology 73: 1406-1412
Lieb K (2010) Hirndoping: Warum wir nicht alles schlucken sollten. Mannheim
Looby A, Earleywine M (2011) Expectation to receive methylphenidate enhances subjective arousal but not cognitive performance. Experimental and Clinical Psychopharmacology 19(6): 433-444
Lucivero F, et al. (2011) Assessing Expectations: Towards a Toolbox for an Ethics of Emerging Technologies. NanoEthics 5(2): 129-141
Lynch G, et al (2011) The likelihood of cognitive enhancement. Pharmacology Biochemistry and Behavior 99(2): 116-29
Maher B, et al. (2008): Pool results: Look who’s doping. Nature 452(7188): 674-675
Martin PA, et al. (2011) Pharmaceutical Cognitive Enhancement: Interrogating the Ethics, Adressing the Issues. In: Segev I, Markram H (2011): 179-192
Mehta MA, et al. (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience 20(6): RC65
Middendorff E, et al. (2012) Formen der Stresskompensation und Leistungssteigerung bei Studierenden. HISBUS-Befragung zur Verbreitung und zu Mustern von Hirndoping und Medikamentenmissbrauch, HIS: Forum Hochschule 01 | 2012, Hannover, http://www.his.de/pdf/pub_fh/fh-201201.pdf
Mittelstraß J (1991) Auf dem Wege zu einer Reparaturethik? In: Wils JP, Mieth D (Hg): Ethik ohne Chance? Erkundungen im technologischen Zeitalter. Tübingen, S 89-108
Mnyusiwalla A, Daar AS, Singer PA (2003) Mind the Gap. Science and Ethics in Nanotechnology. Nanotechnology 14: R9-R13
Moor J, Weckert J (2004) Nanoethics: Assessing the Nanoscale from an Ethical Point of View. In: Baird D, Nordmann A, Schummer J (Hg) Discovering the Nanoscale. Amsterdam
Müller U, et al. (2012) Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 64: 490-495
Nadler R, Reiner PB (2010) A call for data to inform discussion on cognitive enhancement. BioSocieties 5(4): 481-482
Nadler R, Reiner PB (2011) Prototypes or Pragmatics? The Open Question of Public Attitudes Toward Enhancement. AJOB Neuroscience 2(2): 49-50
NEK‐CNE (National Advisory Commission on Biomedical Ethics) (2011) Human Enhancement by means of pharmacological agents (Opinion No. 18, October 2011)
Nida-Rümelin J (Hg) (2005) Angewandte Ethik. Die Bereichsethiken und ihre theoretische Fundierung. Stuttgart
Nordmann A (2007) If and Then: A Critique of Speculative Nanoethics. Nano-Ethics 1(1): 31-46
Nordmann A (2010) A Forensics Of Wishing: Technology Assessment In The Age Of Technoscience. Poiesis & Praxis. International Journal Of Technology Assessment And Ethics Of Science 7(1-2): 5-15
Nordmann A, Rip A (2009) Mind the gap revisited. Nature Nanotechnology 4: 273-274
Nordmann A, Schummer J, Schwarz A (Hg) (2006) Nanotechnologien im Kontext. Berlin
Outram SM, Racine E (2011) Developing Public Health Approaches to Cognitive Enhancement: An Analysis of Current Reports. Public Health Ethics 4(1): 93-105
Outram SM (2011) Ethical Considerations in the Framing of the Cognitive Enhancement Debate. Neuroethics 5(2): 173-184
Outram SM (2010) The use of methylphenidate among students: the future of enhancement? Journal of Medical Ethics 36: 198-202
Palm E, Hansson SO (2006) The case for ethical technology assessment (eTA). Technological Forecasting and Social Change 73(5): 543-558
Patenaude J, et al. (2011) Moral Arguments in the Debate over Nanotechnologies: Are We Talking Past Each Other? NanoEthics 5(3): 285-293
Pereira AG, von Schomberg R, Funtowicz S (2007) Foresight Knowledge Assessment. International Journal of Foresight and Innovation Policy 4: 65-79
Quednow B (2010) Ethics of neuroenhancement: a phantom debate. BioSocieties 5: 153-156
Racine E, et al. (2014) The value and the pitfalls of speculation about science and technology in bioethics: the case of cognitive enhancement. Medicine, Health Care and Philosophy 17(3): 325-37
Racine E, Forlini C (2010) Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs? Ethics Blind Spots in Current Debates. Neuroethics 3(1): 1-4
Ragan CI, Bard J, Singh I (2013) What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology 64: 588-595
Rayne S, Malone L (Hg) (1998) Human Choice and Climate Change, Vol 2 Resources and Technology. Washington D.C.
Reches A, et al. (2013) Network dynamics predict improvement in working memory performance following donepezil administration in healthy young adults. Neuroimage Nov 21, https://doi.org/10.1016/j.neuroimage.2013.11.020
Rehmann-Sutter C, Leach Scully J (2010) Which Ethics for (of) the Nanotechnologies? In: Kaiser M, et al. (2010): 233-252
Repantis D, et al. (2010a) Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research Sep; 62(3): 187-206
Repantis D, et al. (2010b) Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacological Research 61(6): 473-481
Rip A, Kemp R (1998) Technological Change. In: Rayne S, Malone L (1998): 327-399
Rip A, te Kulve H (2008) Constructive technology assessment and sociotechnical scenarios. In: Fisher E, Selin C, Wetmore JM (Hg) The yearbook of nanotechnology in society, Volume 1: Presenting futures. Berlin, S 49-70
Roache R (2008) Ethics, speculation, and values. NanoEthics 2(3): 317-327
Rohbeck J (1993) Technologische Urteilskraft. Zu einer Ethik technischen Handelns. Frankfurt
Rose SPR (2002) ‘Smart drugs’: do they work? Are they ethical? Will they be legal? Nature Reviews Neuroscience 3: 975-979
Royal Society (2012): Human enhancement and the future of work, The Royal Society, London, http://royalsociety.org/policy/projects/human-enhancement/workshop-report/
Sahakian B, Morein-Zhamir S (2007) Professor’s little helper. Nature 450: 1157-1159
Sandel M (2007) The case against perfection. Ethics in the age of genetic engineering. Cambridge
Sattler S, Wiegel C (2013) Test anxiety and cognitive enhancement: the influence of students’ worries on their use of performance-enhancing drugs. Substance Use & Misuse 48: 220–232
Sauter A, Gerlinger K (2012) Der pharmakologisch verbesserte Mensch. Leistungssteigernde Mittel als gesellschaftliche Herausforderung. Studien des Büros für Technikfolgen-Abschätzung beim Deutschen Bundestag, Bd. 34. Berlin
Savulescu J, Bostrom N (Hg) (2008) Human Enhancement. New York
Savulescu J, Bostrom N (2008) Human Enhancement Ethics: The State of the Debate. In: Savulescu J. Bostrom N (2008): 1-22
Schermer M, et al. (2009) The future of psychopharmacological enhancements: Expectations and policies. Neuroethics 2: 75-87
Schleim S (2010) Risiken und Nebenwirkungen der Enhancement-Debatte. Suchtmagazin 2: 49-51
Schöne-Seifert B, et al. (2009) Neuro-Enhancement. Ethik vor neuen Herausforderungen. Paderborn
Schummer J, Baird D (Hg) (2006) Nanotechnology Challenges – Implications for Philosophy, Ethics and Society. Singapur
Segev I, Markram H (Hg) (2011) Augmenting Cognition. Lausanne
Selin C (2011) Negotiating Plausibility: Intervening in the Future of Nanotechnology. Science and Engineering Ethics 17(4): 723-737
Silber BY, et al. (2006) The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology 187: 154-169.
Silver JA, et al. (2004) Effect of anxiolytics on cognitive flexibility in problem solving. Cognitive Behavioral Neurology 17: 93-97
Singh I, Kelleher KJ (2010) Neuroenhancement in Young People: Proposal for Research, Policy, and Clinical Management. AJOB Neuroscience 1(1): 3-16
Skorupinski B, Ott K (2000) Technikfolgenabschätzung und Ethik. Eine Verhältnisbestimmung in Theorie und Praxis. Zürich
Smith ME, Farah M (2011) Are Prescription Stimulants “Smart Pills”? The Epidemiology and Cognitive Neuroscience of Prescription Stimulant Use by Normal Healthy Individuals. Psychological Bulletin 137(5): 717-741
Siep L (2006) Die biotechnische Neuerfindung des Menschen. In: Abel G (Hg) Kreativität. Akten des XX. Deutschen Kongresses für Philosophie. Hamburg, S 306-323
Siune K, Markus E, Calloni M, Felt U, Gorski A, Grunwald A, Rip A, de Semir V, Wyatt S (2009) Challenging Futures of Science in Society. Report of the MASIS Expert Group. Europäische Kommission; Brüssel
Sollie P, Düwell M (Hg) (2009) Evaluating New Technologies, The International Library of Ethics, Law and Technology 3. Dordrecht
Stahl B (2011) IT for a better future: how to integrate ethics, politics and innovation. Journal of Information, Communication & Ethics in Society 9(3): 140-156
Synofzik M (2009) Ethically justified, clinically applicable criteria for physician decision-making in psychopharmacological enhancement. Neuroethics 2: 89-102
Teter CJ, et al. (2006) Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26(10): 1501-1510
Tone A (2005) Listening to the past: History, psychiatry, and anxiety. Canadian Journal of Psychiatry 50(7): 373-380
Turner DC, et al. (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 165: 260-269
Van der Plas A, et al. (2010) Beyond speculative robot ethics: a vision assessment study on the future of the robotic caretaker. In: Accountability in Research: Policies and Quality Assurance 17(6): 299-315
Van Lente H (1993) Promising Technology. The Dynamics of Expectations in Technological Developments. Delft
Viehöver W, Wehling P (2011) Entgrenzung der Medizin? Von der Heilkunst zur Verbesserung des Menschen. Bielefeld
Williams R (2006) Compressed Foresight and Narrative Bias: Pitfalls in Assessing High Technology Futures. Science as Culture 15(4): 327-348
Wolbring G (2008) Why NBIC? Why human performance enhancement? The European Journal of Social Science Research 21: 25-40
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Fachmedien Wiesbaden GmbH, ein Teil von Springer Nature
About this chapter
Cite this chapter
Coenen, C., Ferrari, A., Grunwald, A. (2018). Wider die Begrenzung der Enhancement-Debatte auf angewandte Ethik. In: Erny, N., Herrgen, M., Schmidt, J. (eds) Die Leistungssteigerung des menschlichen Gehirns. Springer VS, Wiesbaden. https://doi.org/10.1007/978-3-658-03683-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-658-03683-6_4
Published:
Publisher Name: Springer VS, Wiesbaden
Print ISBN: 978-3-658-03682-9
Online ISBN: 978-3-658-03683-6
eBook Packages: Social Science and Law (German Language)